Predictive value of phosphorylated axonal neurofilament subunit H for clinical outcome in patients with acute intracerebral hemorrhage

Clinica Chimica Acta

Volumn 424, Issue , 2013, Pages 182-186

  Cai, Jian Yong ^a   Lu, Chuan ^a   Chen, Mao Hua ^a   Ba, Hua Jun ^a   Chen, Xian Dong ^a   Lin, Jian Hu ^a   Sun, Jun ^a  

^a WENZHOU CENTRAL HOSPITAL   (China)

Author keywords

Early neurological deterioration; Intracerebral hemorrhage; Neurofilament; Outcome; Stroke

Indexed keywords

BIOLOGICAL MARKER; PHOSPHORYLATED AXONAL NEUROFILAMENT SUBUNIT H; UNCLASSIFIED DRUG;

ACUTE DISEASE; ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BRAIN HEMORRHAGE; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DISEASE ASSOCIATION; DISEASE DURATION; EARLY NEUROLOGICAL DETERIORATION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MORTALITY; MULTIVARIATE ANALYSIS; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROLOGIC DISEASE; OUTCOME ASSESSMENT; PREDICTIVE VALUE; PRIORITY JOURNAL; PROGNOSIS; PROTEIN BLOOD LEVEL; RANKIN SCALE; RECEIVER OPERATING CHARACTERISTIC; SCORING SYSTEM; SENSITIVITY AND SPECIFICITY; TREATMENT DURATION;

EARLY NEUROLOGICAL DETERIORATION; INTRACEREBRAL HEMORRHAGE; MODIFIED RANKIN SCALE; MRS; NATIONAL INSTITUTES OF HEALTH STROKE SCALE; NEUROFILAMENT; NIHSS; OUTCOME; PHOSPHORYLATED AXONAL NEUROFILAMENT SUBUNIT H; PNF-H; STROKE;

ACUTE DISEASE; AGED; BIOLOGICAL MARKERS; CASE-CONTROL STUDIES; CEREBRAL HEMORRHAGE; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROFILAMENT PROTEINS; PHOSPHORYLATION; PREDICTIVE VALUE OF TESTS; PROGNOSIS; ROC CURVE; SURVIVAL ANALYSIS;

EID: 84880264930     PISSN: 00098981     EISSN: 18733492     Source Type: Journal    
DOI: 10.1016/j.cca.2013.06.019     Document Type: Article

References (30)

1. Petzold A. Neurofilament phosphoforms: surrogate markers for axonal injury, degeneration and loss. J Neurol Sci 2005, 233:183-198.
2. Nylén K., Csajbok L.Z., Ost M., et al. CSF-neurofilament correlates with outcome after aneurysmal subarachnoid hemorrhage. Neurosci Lett 2006, 404:132-136.
3. Zanier E.R., Refai D., Zipfel G.J., et al. Neurofilament light chain levels in ventricular cerebrospinal fluid after acute aneurysmal subarachnoid haemorrhage. J Neurol Neurosurg Psychiatry 2011, 82:157-159.
4. Rosén H., Karlsson J.E., Rosengren L. CSF levels of neurofilament is a valuable predictor of long-term outcome after cardiac arrest. J Neurol Sci 2004, 221:19-24.
5. Norgren N., Rosengren L., Stigbrand T. Increased neurofilament levels in neurological diseases. Brain Res 2003, 987:25-31.
6. Hu Y.Y., He S.S., Wang X.C., et al. Increased levels of phosphorylated neurofilament proteins in cerebrospinal fluid of Alzheimer disease patients. Neurosci Lett 2002, 320:156-160.
7. Matsushige T., Ichiyama T., Kajimoto M., Okuda M., Fukunaga S., Furukawa S. Serial cerebrospinal fluid neurofilament concentrations in bacterial meningitis. J Neurol Sci 2009, 280:59-61.
8. Lewis S.B., Wolper R.A., Miralia L., Yang C., Shaw G. Detection of phosphorylated NF-H in the cerebrospinal fluid and blood of aneurysmal subarachnoid hemorrhage patients. J Cereb Blood Flow Metab 2008, 28:1261-1271.
9. Boylan K., Yang C., Crook J., et al. Immunoreactivity of the phosphorylated axonal neurofilament H subunit (pNF-H) in blood of ALS model rodents and ALS patients: evaluation of blood pNF-H as a potential ALS biomarker. J Neurochem 2009, 111:1182-1191.
10. Goldstein M.E., Sternberger N.H., Sternberger L.A. Phosphorylation protects neurofilaments against proteolysis. J Neuroimmunol 1987, 14:149-160.
11. Huh J.W., Laurer H.L., Raghupathi R., Helfaer M.A., Saatman K.E. Rapid loss and partial recovery of neurofilament immunostaining following focal brain injury in mice. Exp Neurol 2002, 175:198-208.
12. Aronowski J., Cho K.H., Strong R., Grotta J.C. Neurofilament proteolysis after focal ischemia; when do cells die after experimental stroke?. J Cereb Blood Flow Metab 1999, 19:652-660.
13. Shaw G., Yang C., Ellis R., et al. Hyperphosphorylated neurofilament NF-H is a serum biomarker of axonal injury. Biochem Biophys Res Commun 2005, 336:1268-1277.
14. Singh P., Yan J., Hull R., et al. Levels of phosphorylated axonal neurofilament subunit H (pNfH) are increased in acute ischemic stroke. J Neurol Sci 2011, 304:117-121.
15. Hayakawa K., Okazaki R., Ishii K., et al. Phosphorylated neurofilament subunit NF-H as a biomarker for evaluating the severity of spinal cord injury patients, a pilot study. Spinal Cord 2012, 50:493-496.
16. Vajtr D., Benada O., Linzer P., et al. Immunohistochemistry and serum values of S-100B, glial fibrillary acidic protein, and hyperphosphorylated neurofilaments in brain injuries. Soud Lek 2012, 57:7-12.
17. Matsushige T., Inoue H., Fukunaga S., Hasegawa S., Okuda M., Ichiyama T. Serum neurofilament concentrations in children with prolonged febrile seizures. J Neurol Sci 2012, 321:39-42.
18. Zurek J., Bartlová L., Fedora M. Hyperphosphorylated neurofilament NF-H as a predictor of mortality after brain injury in children. Brain Inj 2011, 25:221-226.
19. Žurek J., Fedora M. The usefulness of S100B, NSE, GFAP, NF-H, secretagogin and Hsp70 as a predictive biomarker of outcome in children with traumatic brain injury. Acta Neurochir (Wien) 2012, 154:93-103.
20. Gyorgy A., Ling G., Wingo D., et al. Time-dependent changes in serum biomarker levels after blast traumatic brain injury. J Neurotrauma 2011, 28:1121-1126.
21. Anderson K.J., Scheff S.W., Miller K.M., et al. The phosphorylated axonal form of the neurofilament subunit NF-H (pNF-H) as a blood biomarker of traumatic brain injury. J Neurotrauma 2008, 25:1079-1085.
22. Rodriguez-Luna D., Rubiera M., Ribo M., et al. Ultraearly hematoma growth predicts poor outcome after acute intracerebral hemorrhage. Neurology 2011, 77:1599-1604.
23. Kothari R.U., Brott T., Broderick J.P., et al. The ABCs of measuring intracerebral hemorrhage volumes. Stroke 1996, 27:1304-1305.
24. Brott T., Broderick J., Kothari R., et al. Early hemorrhage growth in patients with intracerebral hemorrhage. Stroke 1997, 28:1-5.
25. Strong M.J., Strong W.L., Jaffe H., Traggert B., Sopper M.M., Pant H.C. Phosphorylation state of the native high-molecular-weight neurofilament subunit protein from cervical spinal cord in sporadic amyotrophic lateral sclerosis. J Neurochem 2001, 76:1315-1325.
26. Schlaepfer W.W., Lee C., Lee V.M., Zimmerman U.J. An immunoblot study of neurofilament degradation in situ and during calcium-activated proteolysis. J Neurochem 1985, 44:502-509.
27. Pant H.C. Dephosphorylation of neurofilament proteins enhances their susceptibility to degradation by calpain. Biochem J 1988, 256:665-668.
28. Johnson G.V., Greenwood J.A., Costello A.C., Troncoso J.C. The regulatory role of calmodulin in the proteolysis of individual neurofilament proteins by calpain. Neurochem Res 1991, 16:869-873.
29. Greenwood J.A., Troncoso J.C., Costello A.C., Johnson G.V. Phosphorylation modulates calpain-mediated proteolysis and calmodulin binding of the 200-kDa and 160-kDa neurofilament proteins. J Neurochem 1993, 61:191-199.
30. Shaw G., Yang C., Zhang L., Cook P., Pike B., Hill W.D. Characterization of the bovine neurofilament NF-M protein and cDNA sequence, and identification of in vitro and in vivo calpain cleavage sites. Biochem Biophys Res Commun 2004, 325:619-625.